Release Date: 23/01/12 10:17 Summary: Acquisition proposal of $7.20 per share from FLSmidth Price Sensitive: Yes Download Document 356.07KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status